Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Sustained release ranolazine formulations

US Patent 6503911 · Granted Jan 7, 2003

Estimated economic value: $7,186,000

Assignee

Inventors

View full patent text on Google Patents →